Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire Strong programmatic growth boosts Mobvista's revenues past $USD 500 million, EBITDA grows to $USD 51.6 million
Media-OutReach Newswire ESR Delivers Stellar Growth with EBITDA and Net Profit up 42.9% and 20.8% to US$549.1 Million and US$245.2 Million, Respectively
Media-OutReach Newswire Thom Signature Design selects Impossible Marketing as their preferred marketing partner